Join BPC and health care leaders as we navigate the dynamic landscape of FDA and CMS regulations. Together, let’s develop strategies to build a resilient and collaborative regulatory infrastructure. Our event is a unique opportunity to engage in discussions that will shape the future of medical advancement and regulatory governance.
Be at the forefront of innovation and join us for the unveiling of the Bipartisan Policy Center’s report, which offers practical, bipartisan steps to enhance collaboration and information exchange between the regulatory bodies. Your presence is not just attendance; it’s an invitation to be an integral part of the conversation that is shaping tomorrow. Don’t miss out on this chance to contribute to the future of health care and regulatory excellence!
Dr. Wilson Bryan | Former Director of the Office of Tissues and Advanced Therapies in the FDA’s Center for Biologics Evaluation and Research; EVP, Drug and Biological Products, Greenleaf Health
Dr. Lee Fleisher | Former CMS Chief Medical Officer and Director; Senior Advisor, BPC
Remy L. Brim | Principal, BGR Group
Jack Rollins | Director of Federal Policy, NAMD
Joyce Frieden | Washington Editor, MedPage Today